CT/NG TESTING MARKET IS ANTICIPATED TO EXPAND FROM $2.1 BILLION IN 2024 TO $5.6 BILLION BY 2034
Market Overview The CT/NG Testing Market is gaining significant attention as healthcare systems worldwide focus on the early detection, prevention, and management of sexually transmitted infections (STIs). CT/NG testing is used to identify Chlamydia trachomatis (CT), which causes chlamydia, and Neisseria gonorrhoeae (NG), which causes gonorrhea. These infections can remain asymptomatic for...
0 Comentários 0 Compartilhamentos 2 Visualizações 0 Anterior